Victhom's Neurobionix business unit achieves ISO 13485:2003 certification
"Achieving ISO 13485:2003 certification is an important corporate milestone for Neurobionix," said Mr. Nader Kameli, Chief Operating Officer of the Neurobionix business unit. "As all commercially available implantable devices have to be manufactured in compliance with ISO 13485 standards, this accomplishment is timely progress towards the commercialization of Neurostep (TM) in 2009," he continued. "Attaining ISO certification is another demonstration of our commitment to the quality of our products and processes. ISO certification will give our customers and business partners added confidence in our ability to develop technologically advanced products at quality standards generally associated with larger companies," he explained.
Most read news
Other news from the department politics & laws
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.